"Effects of Neuromuscular Reeducation Versus Post Facilitation Stretch Technique for Upper Cross Syndrome Among IT Professionals

This study is a randomised control trial and the purpose of this study is to determine the "Effects of Neuromuscular Reeducation Versus Post Facilitation Stretch Technique for Upper Cross Syndrome among IT professionals .

Study Overview

• Status: Recruiting
• Conditions: Upper Cross Syndrome
• Intervention / Treatment: Procedure: Neuromuscular reeducation technique; Procedure: Post Facilitation Stretch

Detailed Description

The purpose of this study is to determine the "Effects of Neuromuscular Reeducation Versus Post Facilitation Stretch Technique for Upper Cross Syndrome among IT professionals

we make 2 groups control and treatment group . we give NMR technique to treatment group and PFS technique to control group in patients with upper cross syndrome.

first we take base line readings of cervical ROM , NPRS AND neck diasbilty index.

after 2 weeks of treatment again we take same readings and compare both readings.

with techniques we also perform strengthning excercise of weal muscles for both groups

• Study Type: Interventional
• Enrollment (Estimated): 44
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Hina Ayub, MS-MSKPT; Phone Number: 03495830798; Email: hinaayub881@gmail.com

Study Locations

• Pakistan
  • Punjab
    • Rawalpindi, Punjab, Pakistan, 46000
      • Recruiting
      • Foundation University College of Physical Therapy
      • Contact: Ruqia Begum, MS-OMPT; Phone Number: 03115532544; Email: ruqia@fui.edu.pk

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• IT profressionals
• 20 - 40 years
• Both genders
• Diagnosed UCS
• Pain from 2 months
• Minimum 4 - 6 hiurs working

Exclusion criteria:

• History of cervical spine
• Fracture
• Trauma to neck

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: NMR Group; On group A we will perform NEUROMUSCULAR REEDUCATION TECHNIQUE: we perform this technique on tight muscles which are: levator scapulae; upper trapezius; pectoralis major	Procedure: Neuromuscular reeducation technique; 5 repetitions of neuromuscular reeducation technique i.e. deep pressure along muscles origin to insertion with active movement of that muscle with 10 seconds rest of each repetitions. Control group will receive 3- 5 repetitions of Post Facilitation stretch to the tight muscles of UCS i.e. 20% maximal isometric contraction of the muscles to be stretched for 5-10 seconds followed by a rapid stretch ( through the new barrier) of 10 seconds. After stretch muscle is allowed to relax in mid range for 10 seconds.
Experimental: PFS Group; On group B we perform POST FACILITATION STRETCH TECHNIQUE on tight muscles same as group A; levator scapulae; upper trapezius; pectoralis major	Procedure: Post Facilitation Stretch; 3- 5 repetitions of Post Facilitation stretch to the tight muscles of UCS i.e. 20% maximal isometric contraction of the muscles to be stretched for 5-10 seconds followed by a rapid stretch ( through the new barrier) of 10 seconds. After stretch muscle is allowed to relax in mid range for 10 seconds.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in ROM	ROM will be measured with goniometer	2 weeks
Pain intensity	It will be measured using Numeric pain rating scale	2 weeks
Neck Disability	It will be measured using Neck disability index	2 weeks

Collaborators and Investigators

• Sponsor: Foundation University Islamabad

Study record dates

Study Major Dates

• Study Start (Actual): July 15, 2024
• Primary Completion (Estimated): July 15, 2025
• Study Completion (Estimated): July 15, 2025

Study Registration Dates

• First Submitted: October 1, 2024
• First Submitted That Met QC Criteria: October 17, 2024
• First Posted (Actual): October 18, 2024

Study Record Updates

• Last Update Posted (Actual): October 18, 2024
• Last Update Submitted That Met QC Criteria: October 17, 2024
• Last Verified: October 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease; Syndrome
• Other Study ID Numbers: FUI/CTR/2024/39

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No